P-BCMA-ALLO1

P-BCMA-ALLO1 CAR-T cells · Poseida Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for P-BCMA-ALLO1, covering 2026-04-24 to 2026-04-24. Get the full timeline:

Most recent: Clinical Trial Update: P-BCMA-ALLO1 Allogeneic CAR-T Cells in the Treatment of Subjects With Multiple Myeloma [Phase 1]